|Bid||74.20 x 100|
|Ask||76.64 x 100|
|Day's range||74.60 - 75.73|
|52-week range||63.43 - 77.27|
|PE ratio (TTM)||29.12|
|Earnings date||26 Jan 2018|
|Forward dividend & yield||1.60 (2.14%)|
|1y target est||75.95|
Procter & Gamble (PG) is slated to announce its fiscal 2Q18 results on Tuesday, January 23, 2018. PG’s sales are expected to benefit from new product launches and traction in innovation-led premium products, especially in China (FXI). The graph above shows that stock prices for consumer product companies are witnessing a downtrend in 2018.
Campbell Soup (CPB) has been struggling to deliver good performance due to adverse operating environment along with intense competition and strained margins.
Zacks Industry Outlook Highlights: SUPERVALU, Church & Dwight, Colgate, Kimberly-Clark and Procter & Gamble
Zacks Industry Outlook Highlights: Procter & Gamble, Colgate-Palmolive, Estee Lauder, Campbell Soup and United Natural Foods
Colgate-Palmolive’s (CL) earnings have benefited in the past several quarters from its focus on productivity and cost-saving initiatives.
Colgate-Palmolive Company (CL) has been witnessing immense pressure of late.This is reflected in the company's strained margins and recently raised cost guidance pertaining to its Global Growth & Efficiency Program.
Colgate-Palmolive Co. (CL) has signed agreements to acquire two professional skin care brands,PCA Skin and EltaMD. The acquisitions are in sync with Colgate's strategy to focus on high-margin oral care, personal care and pet nutrition businesses.
As of November 24, 2017, Colgate-Palmolive (CL) stock was trading at a forward PE multiple of 24.0x, which is higher than its peers.
The majority of analysts providing recommendations on consumer product companies in the United States (SPY) continue to maintain a "neutral" outlook.
Consumer staples have been lagging this year, with the Consumer Staples Select Sector SPDR ETF (XLP) up 7.7%, compared to a 17.3% gain for the S&P 500. However, not all consumer staples stocks are created equal. Today Societe Generale's Iain Simpson and his team upgraded Church & Dwight (CHD) to Buy from Hold, writing that recent weakness provides a good entry point for investors, while downgrading Colgate Palmolive (CL) to Sell from Hold, writing that the stock looks pricey as earnings growth remains "elusive." Simpson reiterated his $54 price target on Church & Dwight, arguing that the stock's premium to other global staples has eroded recently, leaving its valuation looking "undemanding," against a backdrop of better pricing discipline. More detail from his note: US laundry has seen intense price competition in recent quarters, driven by P&G (PG) responding to Henkel’s (HENKY) recent acquisition of Sun. However, with oil prices now up 40%+ from their June lows of $40 a barrel, we expect rising input costs to drive greater industry price discipline in 2018, as seen in previous commodity cycles. CHD is a highly acquisitive company, and tends to book a large part of the purchase price of each deal as non-goodwill intangible assets which are then amortized down over time.
Colgate-Palmolive Co. agreed to settle a lawsuit claiming its talcum-powder products caused a Pennsylvania woman to develop mesothelioma, a fatal lung disease tied to asbestos exposure.
NEW YORK, Nov. 07, 2017-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Colgate-Palmolive ...
After its 3Q17 earnings, ~72.0% of the analysts covering Colgate-Palmolive stock maintained a “hold” rating, 22.0% recommended a “buy,” and 4.0% gave a “sell” rating.
Colgate-Palmolive’s (CL) adjusted operating margin decreased 160 basis points to 24.8% in 3Q17, reflecting flat gross margins and increased SG&A costs.
Colgate-Palmolive (CL) reported its 3Q17 earnings on October 27. CL’s adjusted earnings per share of $0.73 were in line with estimates and remained flat on a year-over-year basis.
Colgate-Palmolive Co. (CL) posted adjusted earnings of 73 cents a share in third-quarter 2017, in line with the Zacks Consensus Estimate and flat with the prior-year quarter.